🇺🇸 FDA
Patent

US 8936792

Pseudomonas exotoxin a with reduced immunogenicity

granted A61KA61K38/00A61P

Quick answer

US patent 8936792 (Pseudomonas exotoxin a with reduced immunogenicity) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K38/00, A61P, A61P35/00, A61P35/02